WCN26-2303 EXTRACORPOREAL SUPPORT THERAPIES GUIDED BY SEPSIS PHENOTYPES: A CASE SERIES APPROACH TO PRECISION MEDICINE

Read full text Summarise with VIRAT
Authors: Maiko Alejandro Tavera Díaz, JAUN FERNANDO MAMANI OCHOA, Annia Aguilar Loayza
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Sepsis is a heterogeneous clinical syndrome with distinct phenotypes that influence prognosis and therapeutic response. Molecular profiling using accessible biomarkers enables personalized interventions. Five principal phenotypes have been identified: Immunoparalysis, Endothelial activity, Hepatobiliary dysfunction, Macrophage Activation Syndrome (MAS), and Mixed. Additionally, five dynamic subtypes of endothelial activity are recognized: TTP-like, HUS, SIC, Fibrinolytic, and Thrombotic. This case series illustrates how biomarker-guided stratification informs extracorporeal therapies, transitioning from empirical care to precision medicine.

Fields of Study & Subjects

Sepsis Diagnosis and Treatment Acute Kidney Injury Research Inflammation biomarkers and pathways

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105187–105187
Publication date
25 March 2026
Language
EN